25 Nov 2025
19:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology : Publication d’une notification de transparence de Fortress Investment Group LLC (Article 14 §1 de la loi du 2 mai 2007)
|
20103010 Biotechnology |
New |
25 Nov 2025
19:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
|
20103010 Biotechnology |
New |
14 Nov 2025
19:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)
|
20103010 Biotechnology |
New |
14 Nov 2025
19:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
|
20103010 Biotechnology |
New |
29 Sep 2025
18:30 CEST |
CELYAD ONCOLOGY |
Celyad Oncology Announces Research Facility Divestiture
|
20103010 Biotechnology |
Other subject |
29 Sep 2025
18:30 CEST |
CELYAD ONCOLOGY |
Celyad Oncology annonce la cession de ses installations de recherche
|
20103010 Biotechnology |
Other subject |
25 Sep 2025
18:30 CEST |
CELYAD ONCOLOGY |
Celyad Oncology Reports First Half Year 2025 Financial Results
|
20103010 Biotechnology |
Other subject |
25 Sep 2025
18:30 CEST |
CELYAD ONCOLOGY |
Celyad Oncology publie ses résultats financiers du premier semestre 2025
|
20103010 Biotechnology |
Other subject |
11 Sep 2025
18:30 CEST |
CELYAD ONCOLOGY |
Celyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLC (Article 14 §1 de la loi du 2 mai 2007)
|
20103010 Biotechnology |
Other subject |
11 Sep 2025
18:30 CEST |
CELYAD ONCOLOGY |
Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
|
20103010 Biotechnology |
Other subject |
04 Sep 2025
07:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
|
20103010 Biotechnology |
Other subject |
04 Sep 2025
07:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)
|
20103010 Biotechnology |
Other subject |
26 Aug 2025
08:29 CEST |
CELYAD ONCOLOGY |
Celyad Oncology annonce la cessation des activités R&D
|
20103010 Biotechnology |
Other subject |
26 Aug 2025
08:29 CEST |
CELYAD ONCOLOGY |
Celyad Oncology Announces Discontinuation of R&D Activities
|
20103010 Biotechnology |
Other subject |
13 Aug 2025
18:30 CEST |
CELYAD ONCOLOGY |
Celyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLC
|
20103010 Biotechnology |
Other subject |
13 Aug 2025
18:30 CEST |
CELYAD ONCOLOGY |
Celyad Oncology SA: Publication of a Transparency Notification Received from Fortress Investment Group LLC
|
20103010 Biotechnology |
Other subject |
07 Aug 2025
18:30 CEST |
CELYAD ONCOLOGY |
Celyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)
|
20103010 Biotechnology |
Other subject |
07 Aug 2025
18:30 CEST |
CELYAD ONCOLOGY |
Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
|
20103010 Biotechnology |
Other subject |
28 Jul 2025
22:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology annonce un placement privé d’un million d’euros
|
20103010 Biotechnology |
Other financial transaction |
28 Jul 2025
22:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology Announces €1 Million Private Placement
|
20103010 Biotechnology |
Other financial transaction |
24 Jun 2025
19:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology annonce une revue de sa stratégie d’entreprise
|
20103010 Biotechnology |
Corporate life |
24 Jun 2025
19:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology Announces Strategic Review
|
20103010 Biotechnology |
Corporate life |
02 Apr 2025
19:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology publie ses résultats financiers pour l'année 2024 ainsi que les récents évènements marquants de son activité
|
20103010 Biotechnology |
Other subject |
02 Apr 2025
19:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology Reports Full Year 2024 Financial Results and Recent Business Highlights
|
20103010 Biotechnology |
Other subject |
18 Feb 2025
07:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology annonce la publication des données précliniques et cliniques de CYAD-211 apportant la preuve de concept de sa plateforme shRNA basée sur les miRNAs
|
20103010 Biotechnology |
Other subject |
18 Feb 2025
07:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology announces the publication of the preclinical and clinical data of CYAD-211 providing proof-of-concept of its miRNA-based shRNA platform
|
20103010 Biotechnology |
Other subject |
07 Oct 2024
18:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology Présentera au Congrès Annuel SITC 2024
|
20103010 Biotechnology |
Meetings / events |
07 Oct 2024
18:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology to Present at the 2024 SITC Annual Meeting
|
20103010 Biotechnology |
Meetings / events |
16 Sep 2024
18:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology Announces Appointment of Matt Kane as Chief Executive Officer
|
20103010 Biotechnology |
Corporate life |
16 Sep 2024
18:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology annonce la nomination de Matt Kane au poste de CEO
|
20103010 Biotechnology |
Corporate life |
13 Sep 2024
07:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology Reports First Half Year 2024 Financial Results and Recent Business Highlights
|
20103010 Biotechnology |
Corporate life |
13 Sep 2024
07:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology publie ses résultats financiers pour le premier semestre 2024 ainsi que les récents évènements marquants de son activité
|
20103010 Biotechnology |
Corporate life |
04 Apr 2024
07:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights
|
20103010 Biotechnology |
Corporate life |
04 Apr 2024
07:00 CEST |
CELYAD ONCOLOGY |
Celyad Oncology publie ses résultats financiers pour l'année 2023 ainsi que les récents évènements marquants
|
20103010 Biotechnology |
Corporate life |
08 Feb 2024
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology annonce son intention de mettre fin à ses obligations de déclaration à la SEC
|
20103010 Biotechnology |
Other subject |
08 Feb 2024
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology Announces Intention to Terminate SEC Reporting Obligations
|
20103010 Biotechnology |
Other subject |
16 Jan 2024
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024
|
20103010 Biotechnology |
Corporate life |
16 Jan 2024
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook
|
20103010 Biotechnology |
Corporate life |
20 Dec 2023
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLC
|
20103010 Biotechnology |
Other subject |
20 Dec 2023
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC
|
20103010 Biotechnology |
Other subject |
15 Dec 2023
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
|
20103010 Biotechnology |
Other subject |
15 Dec 2023
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)
|
20103010 Biotechnology |
Other subject |
04 Dec 2023
14:34 CET |
CELYAD ONCOLOGY |
Celyad Announces Management Change
|
20103010 Biotechnology |
Corporate life |
04 Dec 2023
14:34 CET |
CELYAD ONCOLOGY |
Celyad annonce un changement de direction
|
20103010 Biotechnology |
Corporate life |
30 Nov 2023
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology SA: Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)
|
20103010 Biotechnology |
Legal |
30 Nov 2023
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology SA : Publication d’une notification de transparence reçue de Tolefi SA (Article 14 §1 de la loi du 2 mai 2007)
|
20103010 Biotechnology |
Legal |
21 Nov 2023
22:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLC
|
20103010 Biotechnology |
Other subject |
21 Nov 2023
22:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology SA: Publication of a transparency notification received from Fortress Investment Group LLC
|
20103010 Biotechnology |
Other subject |
14 Nov 2023
22:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)
|
20103010 Biotechnology |
Other subject |
14 Nov 2023
22:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
|
20103010 Biotechnology |
Other subject |